Explore the vast range of titles available.

Observations of a stellar occultation by (10199) Chariklo, a minor body that orbits the Sun between Jupiter and Neptune, reveal that it has a ring system, a property previously observed only for the four giant planets of the Solar System. Tiny Chariklo has its own ring system Observations of a stellar occultation by (10199) Chariklo, a Centaur-class outer-system asteroid orbiting between Saturn and Uranus, reveal that it has a ring system, a feature previously observed only for the four giant planets. Chariklo, with a diameter of about 250 km, has two narrow and dense rings separated by a small gap, probably due to the presence of a (yet-to-be-found) kilometre-sized satellite. The discovery of these rings raises questions about the formation and dynamical evolution of planetary rings. For one thing, it seems likely that planetary rings are much more common than previously thought. Hitherto, rings have been found exclusively around the four giant planets in the Solar System 1 . Rings are natural laboratories in which to study dynamical processes analogous to those that take place during the formation of planetary systems and galaxies. Their presence also tells us about the origin and evolution of the body they encircle. Here we report observations of a multichord stellar occultation that revealed the presence of a ring system around (10199) Chariklo, which is a Centaur—that is, one of a class of small objects orbiting primarily between Jupiter and Neptune—with an equivalent radius of 124   9 kilometres (ref. 2 ). There are two dense rings, with respective widths of about 7 and 3 kilometres, optical depths of 0.4 and 0.06, and orbital radii of 391 and 405 kilometres. The present orientation of the ring is consistent with an edge-on geometry in 2008, which provides a simple explanation for the dimming 3 of the Chariklo system between 1997 and 2008, and for the gradual disappearance of ice and other absorption features in its spectrum over the same period 4 , 5 . This implies that the rings are partly composed of water ice. They may be the remnants of a debris disk, possibly confined by embedded, kilometre-sized satellites.

Pluto's twin is out in the cold Four trans-Neptunian objects are currently recognized as dwarf planets: Eris, Haumea, Makemake and Pluto. Of these, the 'demoted' planet Pluto has been studied for many years and has a detected atmosphere. The others are difficult to observe because of their extreme distance from the Sun, but a stellar occultation event on 6 November 2010 provided an opportunity for a closer look at Eris. The data obtained reveal Eris as a 'twin' for Pluto in terms of size, and previous work showed the two to have similar surface compositions. Eris, however, has no detectable atmosphere and its surface is bright, possibly a result of atmospheric collapse in an extremely cold environment. The dwarf planet Eris is a trans-Neptunian object with an orbital eccentricity of 0.44, an inclination of 44 degrees and a surface composition very similar to that of Pluto 1 . It resides at present at 95.7 astronomical units (1  au is the Earth-Sun distance) from Earth, near its aphelion and more than three times farther than Pluto. Owing to this great distance, measuring its size or detecting a putative atmosphere is difficult. Here we report the observation of a multi-chord stellar occultation by Eris on 6 November 2010 ut . The event is consistent with a spherical shape for Eris, with radius 1,163 ± 6 kilometres, density 2.52 ± 0.05 grams per cm 3 and a high visible geometric albedo, . No nitrogen, argon or methane atmospheres are detected with surface pressure larger than ∼1 nanobar, about 10,000 times more tenuous than Pluto's present atmosphere 2 , 3 , 4 , 5 . As Pluto's radius is estimated 3 , 4 , 5 , 6 , 7 , 8 to be between 1,150 and 1,200 kilometres, Eris appears as a Pluto twin, with a bright surface possibly caused by a collapsed atmosphere, owing to its cold environment. We anticipate that this atmosphere may periodically sublimate as Eris approaches its perihelion, at 37.8 astronomical units from the Sun.

Until now, rings have been detected in the Solar System exclusively around the four giant planets. Here we report the discovery of the first minor-body ring system around the Centaur object (10199) Chariklo, a body with equivalent radius 124\\(\\pm\\)9 km. A multi-chord stellar occultation revealed the presence of two dense rings around Chariklo, with widths of about 7 km and 3 km, optical depths 0.4 and 0.06, and orbital radii 391 and 405 km, respectively. The present orientation of the ring is consistent with an edge-on geometry in 2008, thus providing a simple explanation for the dimming of Chariklo's system between 1997 and 2008, and for the gradual disappearance of ice and other absorption features in its spectrum over the same period. This implies that the rings are partially composed of water ice. These rings may be the remnants of a debris disk, which were possibly confined by embedded kilometre-sized satellites.

Combining stellar occultation observations probing Pluto's atmosphere from 1988 to 2013 and models of energy balance between Pluto's surface and atmosphere, we conclude that Pluto's atmosphere does not collapse at any point in its 248-year orbit. The occultation results show an increasing atmospheric pressure with time in the current epoch, a trend present only in models with a high thermal inertia and a permanent N2 ice cap at Pluto's north rotational pole.

We present results from a multi-chord Pluto stellar occultation observed on 29 June 2015 from New Zealand and Australia. This occurred only two weeks before the NASA New Horizons flyby of the Pluto system and serves as a useful comparison between ground-based and space results. We find that Pluto's atmosphere is still expanding, with a significant pressure increase of 5\\(\\pm\\)2\\% since 2013 and a factor of almost three since 1988. This trend rules out, as of today, an atmospheric collapse associated with Pluto's recession from the Sun. A central flash, a rare occurrence, was observed from several sites in New Zealand. The flash shape and amplitude are compatible with a spherical and transparent atmospheric layer of roughly 3~km in thickness whose base lies at about 4~km above Pluto's surface, and where an average thermal gradient of about 5 K~km\\(^{-1}\\) prevails. We discuss the possibility that small departures between the observed and modeled flash are caused by local topographic features (mountains) along Pluto's limb that block the stellar light. Finally, using two possible temperature profiles, and extrapolating our pressure profile from our deepest accessible level down to the surface, we obtain a possible range of 11.9-13.7~\\(\\mu\\)bar for the surface pressure.

The current scenario of Agroforestry Systems (AFS) worldwide lacks specific machinery, resulting in practically all operations being carried out manually. This leads to a significant physical effort for small-scale farmers and limits the implementation of AFS to small areas. The objective of the study was to evaluate the suitability of existing machines for performing agroforestry tasks. This research utilizes Descriptive Statistics and Exponentially Weighted Moving Average methods to evaluate the data and compare the treatments, where different machines are used to cut Mombaça grass (Megathyrsus maximus Jacq): (i) costal brushcutter (CBC); (ii) tractor-mounted rotary brushcutter (RBC); and (iii) mini grain reaper machine (GRM). The experiments were conducted in Jaguariúna, São Paulo, Brazil. GRM is recommended for achieving greater biomass production, reducing raking time, and minimizing operational costs. CBC is suitable for smaller areas due to its affordability and slow operation, which requires significant physical effort. RBC is recommended for reducing working time, physical effort, and personnel costs, making it suitable for larger-scale contexts.

The current scenario of Agroforestry Systems (AFS) worldwide lacks specific machinery, resulting in practically all operations being carried out manually. This leads to a significant physical effort for small-scale farmers and limits the implementation of AFS to small areas. The objective of the study was to evaluate the suitability of existing machines for performing agroforestry tasks. This research utilizes Descriptive Statistics and Exponentially Weighted Moving Average methods to evaluate the data and compare the treatments, where different machines are used to cut Mombaça grass (Megathyrsus maximus Jacq): (i) costal brushcutter (CBC); (ii) tractor-mounted rotary brushcutter (RBC); and (iii) mini grain reaper machine (GRM). The experiments were conducted in Jaguariúna, São Paulo, Brazil. GRM is recommended for achieving greater biomass production, reducing raking time, and minimizing operational costs. CBC is suitable for smaller areas due to its affordability and slow operation, which requires significant physical effort. RBC is recommended for reducing working time, physical effort, and personnel costs, making it suitable for larger-scale contexts.

The diagnosis of iron disturbances usually includes the evaluation of serum parameters. Serum iron is assumed to be entirely bound to transferrin, and transferrin saturation—the ratio between the serum iron concentration and serum transferrin—usually reflects iron availability. Additionally, serum ferritin is commonly used as a surrogate of tissue iron levels. Low serum ferritin values are interpreted as a sign of iron deficiency, and high values are the main indicator of pathological iron overload. However, in situations of inflammation, serum ferritin levels may be very high, independently of tissue iron levels. This presents a particularly puzzling challenge for the clinician evaluating the overall iron status of the patient in the presence of an inflammatory condition. The increase in serum ferritin during inflammation is one of the enigmas regarding iron metabolism. Neither the origin, the mechanism of release, nor the effects of serum ferritin are known. The use of serum ferritin as a biomarker of disease has been rising, and it has become increasingly diverse, but whether or not it contributes to controlling the disease or host pathology, and how it would do it, are important, open questions. These will be discussed here, where we spotlight circulating ferritin and revise the recent clinical and preclinical data regarding its role in health and disease.

Age-related macular degeneration (AMD) is an eye disease that occurs in patients over 50 years old. Early diagnosis enables timely treatment to stabilize disease progression. However, the fact that the disease is asymptomatic in its early stages can delay treatment until it progresses. As such, screening in specific contexts can be an early detection tool to reduce the clinical and social impact of the disease. Assess the effectiveness of screening methods for early detection of AMD in adults aged 50 years or older. A systematic review of comparative observational studies on AMD screening methods in those aged 50 years or older, compared with no screening or any other strategy. A literature search was conducted in the MEDLINE (via PubMed), Embase, Cochrane Library and Lilacs database. A total of 5,290 studies were identified, three of which met the inclusion criteria and were selected for the systematic review. A total of 8,733 individuals (16,780 eyes) were included in the analysis. The screening methods assessed were based on optical coherence tomography (OCT) compared with color fundus photography, and OCT and telemedicine testing compared to a standard eye exam. The systematized data are limited and only suggest satisfactory performance in early screening of the population at risk of developing AMD. OCT and the telemedicine technique showed promising results in AMD screening. However, methodological problems were identified in the studies selected and the level of evidence was considered low.

Pembrolizumab has shown efficacy in persistent, recurrent, or metastatic cervical cancer. The effect of chemoradiotherapy might be enhanced by immunotherapy. In this phase 3 trial, we assessed the efficacy and safety of adding pembrolizumab to chemoradiotherapy in locally advanced cervical cancer. In this randomised, double-blind, placebo-controlled, phase 3 ENGOT-cx11/GOG-3047/KEYNOTE-A18 clinical trial, adults (age ≥18 years) at 176 medical centres in 30 countries with newly diagnosed, high-risk, locally advanced cervical cancer were randomly assigned (1:1) using an interactive voice-response system with integrated web response to receive 5 cycles of pembrolizumab (200 mg) or placebo every 3 weeks plus chemoradiotherapy, followed by 15 cycles of pembrolizumab (400 mg) or placebo every 6 weeks. Randomisation was stratified by planned external beam radiotherapy type (intensity-modulated radiotherapy or volumetric-modulated arc therapy vs non-intensity-modulated radiotherapy or non-volumetric-modulated arc therapy), cervical cancer stage at screening (International Federation of Gynecology and Obstetrics 2014 stage IB2–IIB node positive vs stage III–IVA), and planned total radiotherapy (external beam radiotherapy plus brachytherapy) dose (<70 Gy vs ≥70 Gy equivalent dose in 2 Gy fractions). Primary endpoints were progression-free survival per Response Evaluation Criteria in Solid Tumours version 1.1—by investigator or by histopathologic confirmation of suspected disease progression—and overall survival. Primary analysis was conducted in the intention-to-treat population, which included all randomly allocated participants. Safety was assessed in the as-treated population, which included all randomly allocated patients who received at least one dose of study treatment. This study is registered with ClinicalTrials.gov, NCT04221945, and is closed to new participants. Between June 9, 2020, and Dec 15, 2022, 1060 participants were randomly assigned to treatment, with 529 assigned to the pembrolizumab–chemoradiotherapy group and 531 to the placebo–chemoradiotherapy group. At data cutoff (Jan 9, 2023), median follow-up was 17·9 months (IQR 11·3–22·3) in both treatment groups. Median progression-free survival was not reached in either group; rates at 24 months were 68% in the pembrolizumab–chemoradiotherapy group versus 57% in the placebo–chemoradiotherapy group. The hazard ratio (HR) for disease progression or death was 0·70 (95% CI 0·55–0·89, p=0·0020), meeting the protocol-specified primary objective. Overall survival at 24 months was 87% in the pembrolizumab–chemoradiotherapy group and 81% in the placebo–chemoradiotherapy group (information fraction 42·9%). The HR for death was 0·73 (0·49–1·07); these data have not crossed the boundary of statistical significance. Grade 3 or higher adverse event rates were 75% in the pembrolizumab–chemoradiotherapy group and 69% in the placebo–chemoradiotherapy group. Pembrolizumab plus chemoradiotherapy significantly improved progression-free survival in patients with newly diagnosed, high-risk, locally advanced cervical cancer. Merck Sharp & Dohme, a subsidiary of Merck & Co (MSD).